Sen. Julie A. Morrison

Filed: 4/16/2026

 

 


 

 


 
10400SB0692sam001LRB104 07052 KTG 36919 a

1
AMENDMENT TO SENATE BILL 692

2    AMENDMENT NO. ______. Amend Senate Bill 692 by replacing
3everything after the enacting clause with the following:
 
4    "Section 5. The Illinois Public Aid Code is amended by
5adding Section 5-70 as follows:
 
6    (305 ILCS 5/5-70 new)
7    Sec. 5-70. Management and treatment of obesity.
8    (a) Definitions. As used in this Section:
9    "FDA-approved obesity medication" means any medication
10approved by the United States Food and Drug Administration
11with an indication for chronic weight management in patients
12with an obesity diagnosis.
13    "Intensive health behavior and lifestyle treatment" means
14an evidence-based, intensive, multi-component behavioral or
15lifestyle modification intervention that supports healthy
16weight management and is delivered in-person or through

 

 

10400SB0692sam001- 2 -LRB104 07052 KTG 36919 a

1telehealth services as defined in the Telehealth Act.
2    (b) Management and treatment of obesity; coverage
3required. The Department shall:
4        (1) seek federal authorization to provide intensive
5    health behavior and lifestyle treatment for the chronic
6    disease of obesity; and
7        (2) develop the criteria to cover all FDA-approved
8    obesity medications.
9    (c) Upon receiving federal authorization, the Department
10shall implement this Section and notify medical assistance
11enrollees in writing about the availability of treatment for
12the chronic disease of obesity as provided under this Section.
13    (d) This Section does not prohibit the Department from
14applying utilization management to determine the medical
15necessity for treatment of the chronic disease of obesity if
16appropriateness and medical necessity determinations are made
17in the same manner as those determinations are made for the
18treatment of any other illness, condition, or disorder covered
19by a managed care contract.
20    (e) Intensive health behavior and lifestyle treatment may
21include interventions certified by or recognized by the
22Centers for Disease Control and Prevention or recommended by
23current clinical standards of care. The services may be
24provided in office, virtual, or community-based settings to
25support patient access and needs.
26    (f) Coverage criteria for FDA-approved obesity medications

 

 

10400SB0692sam001- 3 -LRB104 07052 KTG 36919 a

1shall not be more restrictive than the FDA-approved
2indications for those treatments.".